Journal article
Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study
Abstract
BackgroundTaxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 2–3 days after taxane-based chemotherapy and lasting up to 7 days. In the absence of validated tools, many studies use the presence of both the myalgia and arthralgia components of the Common Terminology Criteria for Adverse Events (CTCAE) to define TAPS. The present study prospectively evaluated the frequency, severity, and impact of TAPS in …
Authors
Fernandes R; Mazzarello S; Joy AA; Pond GR; Hilton J; Ibrahim MFK; Canil C; Ong M; Stober C; Vandermeer L
Journal
Supportive Care in Cancer, Vol. 26, No. 9, pp. 3073–3081
Publisher
Springer Nature
Publication Date
9 2018
DOI
10.1007/s00520-018-4161-x
ISSN
0941-4355